AGP Executive Report
Last update: 7 hours agoUK Medical Access: Boots has launched SureLeaf, the first private medical-cannabis service from a UK high-street pharmacy. Adults aged 25 and over with chronic pain, anxiety or insomnia may qualify after conventional treatments fail; a University of Nottingham partnership will study patient outcomes. Workplace Safety: Federal funding will support University of Oklahoma research into cannabis-industry workers’ exposure to hazards such as carbon dioxide and plant particulates, and ways to reduce risks. Patient Health: A Rutgers study of more than 415,000 U.S. adults found cannabis use disorder was linked to 57% higher odds of suicidal thoughts from 2014 to 2023. The finding concerns people with the disorder, not all cannabis users. Global Industry: Morocco’s first locally made cannabis-based epilepsy medicine has reached pharmacies, while eThekwini is advancing a three-year cannabis and hemp commercialisation pilot.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.